drugset / Trial / NCT01001468
Study to Assess VB-201 in Patients With Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to examine the efficacy, safety and tolerability of VB-201 as compared with placebo on measures of disease activity in patients with psoriasis.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VB-201 | Small molecule | 20 mg | Oral |
| Subject | VB-201 | Small molecule | 80 mg | Oral |